This is a preview of subscription content, log in via an institution to check access.
Reference
Savitz ST, et al. Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases. Cancer : 15 Sep 2015. Available from: URL: http://doi.org/10.1002/cncr.29642
Rights and permissions
About this article
Cite this article
Novel neurocognitive-sparing radiotherapy worth its cost. PharmacoEcon Outcomes News 737, 23 (2015). https://doi.org/10.1007/s40274-015-2469-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2469-z